非小细胞肺癌术后随访中国胸外科专家共识

2020-10-30 中国医师协会胸外科医师分会 中国胸心血管外科临床杂志.2020.27(10):1-7.

外科手术是非小细胞肺癌的重要治疗手段,其术后定期随访是早期发现和治疗肿瘤复发转移或第二原发肿瘤的有效方法,可提高患者的生活质量,改善预后。本共识旨在完善我国非小细胞肺癌患者术后随访方案,为负责非小细胞

中文标题:

非小细胞肺癌术后随访中国胸外科专家共识

发布日期:

2020-10-30

简要介绍:

外科手术是非小细胞肺癌的重要治疗手段,其术后定期随访是早期发现和治疗肿瘤复发转移或第二原发肿瘤的有效方法,可提高患者的生活质量,改善预后。本共识旨在完善我国非小细胞肺癌患者术后随访方案,为负责非小细胞肺癌患者术后随访的同道提供参考,进一步提高我国肺癌规范化诊疗水平。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=非小细胞肺癌术后随访中国胸外科专家共识_刘伦旭.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ca3031c002009e17, title=非小细胞肺癌术后随访中国胸外科专家共识, enTitle=, guiderFrom=中国胸心血管外科临床杂志.2020.27(10):1-7., authorId=0, author=, summary=外科手术是非小细胞肺癌的重要治疗手段,其术后定期随访是早期发现和治疗肿瘤复发转移或第二原发肿瘤的有效方法,可提高患者的生活质量,改善预后。本共识旨在完善我国非小细胞肺癌患者术后随访方案,为负责非小细胞, cover=https://img.medsci.cn/20201118/1605631172526_2020535.jpg, journalId=0, articlesId=null, associationId=320, associationName=中国医师协会胸外科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Fri Oct 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>外科手术是非小细胞肺癌的重要治疗手段,其术后定期随访是早期发现和治疗肿瘤复发转移或第二原发肿瘤的有效方法,可提高患者的生活质量,改善预后。本共识旨在完善我国非小细胞肺癌患者术后随访方案,为负责非小细胞肺癌患者术后随访的同道提供参考,进一步提高我国肺癌规范化诊疗水平。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=276, tagName=非小细胞肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=276, guiderKeyword=非小细胞肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4451, appHits=270, showAppHits=0, pcHits=1042, showPcHits=4181, likes=1, shares=13, comments=20, approvalStatus=1, publishedTime=Wed Nov 18 00:59:52 CST 2020, publishedTimeString=2020-10-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Nov 18 00:39:42 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:30:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=非小细胞肺癌术后随访中国胸外科专家共识_刘伦旭.pdf)])
非小细胞肺癌术后随访中国胸外科专家共识_刘伦旭.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1081331, encodeId=56f31081331cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zFdcBj01aZ14pu4YBD4Pp305D1M79j9aib4SXLM1pGkRjzv5ApugWDNXeEcbjtOxQOIl9xr8NOcGHiaKicKbQ6F1Q/132, createdBy=38e25200291, createdName=ms1616467909530241, createdTime=Fri Dec 17 23:00:29 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070510, encodeId=b6d110e051063, content=123, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Mon Nov 15 20:09:56 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065565, encodeId=7de7106556531, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063618, encodeId=bdf9106361813, content=主要是把靶向药用起来了,但是没进医保, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 24 23:18:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003028, encodeId=c2fb100302822, content=围手术期要关注什么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df85475899, createdName=睿达, createdTime=Tue Jul 27 15:56:10 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-12-17 ms1616467909530241

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1081331, encodeId=56f31081331cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zFdcBj01aZ14pu4YBD4Pp305D1M79j9aib4SXLM1pGkRjzv5ApugWDNXeEcbjtOxQOIl9xr8NOcGHiaKicKbQ6F1Q/132, createdBy=38e25200291, createdName=ms1616467909530241, createdTime=Fri Dec 17 23:00:29 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070510, encodeId=b6d110e051063, content=123, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Mon Nov 15 20:09:56 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065565, encodeId=7de7106556531, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063618, encodeId=bdf9106361813, content=主要是把靶向药用起来了,但是没进医保, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 24 23:18:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003028, encodeId=c2fb100302822, content=围手术期要关注什么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df85475899, createdName=睿达, createdTime=Tue Jul 27 15:56:10 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-11-15 ms9000001410187120

    123

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1081331, encodeId=56f31081331cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zFdcBj01aZ14pu4YBD4Pp305D1M79j9aib4SXLM1pGkRjzv5ApugWDNXeEcbjtOxQOIl9xr8NOcGHiaKicKbQ6F1Q/132, createdBy=38e25200291, createdName=ms1616467909530241, createdTime=Fri Dec 17 23:00:29 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070510, encodeId=b6d110e051063, content=123, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Mon Nov 15 20:09:56 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065565, encodeId=7de7106556531, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063618, encodeId=bdf9106361813, content=主要是把靶向药用起来了,但是没进医保, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 24 23:18:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003028, encodeId=c2fb100302822, content=围手术期要关注什么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df85475899, createdName=睿达, createdTime=Tue Jul 27 15:56:10 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-10-31 小白努力长高高

    受益匪浅,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1081331, encodeId=56f31081331cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zFdcBj01aZ14pu4YBD4Pp305D1M79j9aib4SXLM1pGkRjzv5ApugWDNXeEcbjtOxQOIl9xr8NOcGHiaKicKbQ6F1Q/132, createdBy=38e25200291, createdName=ms1616467909530241, createdTime=Fri Dec 17 23:00:29 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070510, encodeId=b6d110e051063, content=123, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Mon Nov 15 20:09:56 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065565, encodeId=7de7106556531, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063618, encodeId=bdf9106361813, content=主要是把靶向药用起来了,但是没进医保, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 24 23:18:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003028, encodeId=c2fb100302822, content=围手术期要关注什么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df85475899, createdName=睿达, createdTime=Tue Jul 27 15:56:10 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-10-24 小白努力长高高

    主要是把靶向药用起来了,但是没进医保

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1081331, encodeId=56f31081331cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zFdcBj01aZ14pu4YBD4Pp305D1M79j9aib4SXLM1pGkRjzv5ApugWDNXeEcbjtOxQOIl9xr8NOcGHiaKicKbQ6F1Q/132, createdBy=38e25200291, createdName=ms1616467909530241, createdTime=Fri Dec 17 23:00:29 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070510, encodeId=b6d110e051063, content=123, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebc35713656, createdName=ms9000001410187120, createdTime=Mon Nov 15 20:09:56 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065565, encodeId=7de7106556531, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063618, encodeId=bdf9106361813, content=主要是把靶向药用起来了,但是没进医保, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 24 23:18:24 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003028, encodeId=c2fb100302822, content=围手术期要关注什么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df85475899, createdName=睿达, createdTime=Tue Jul 27 15:56:10 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-07-27 睿达

    围手术期要关注什么

    0

拓展阅读

ASCO指南:IV期非小细胞肺癌的维持治疗(2009)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2009-12-20

2010CCO 晚期非小细胞肺癌一线全身化疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-01-01

2010ESMO临床实践指南:早期和局部晚期(非转移性)非小细胞肺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01

2010ESMO临床实践指南:转移性非小细胞肺癌的诊断、治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01